Swipp

Swipp is a startup based in Sweden. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Swipp develops orally dissolving buccal films containing midazolam for the treatment of acute epileptic seizures, focusing on faster drug uptake and easier administration for patients and caregivers. Their approach uses well-established drug substances to shorten development times, aiming to reach first clinical trials within about three years.